Russell Investments Group
CASC

Russell Investments Group’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Russell Investments Group’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11,200
Closed -$43K – 3095
2017
Q4 		$43K Buy
+11,200
New +$45.9K ﹤0.01% 2884

Russell Investments Group's CASC Position: Q1 2018 in Review

Russell Investments Group sold out of Cascadian Therapeutics, Inc. (CASC) in Q1 2018, closing a stake of 11,200 shares — an estimated $43K sold.

Russell Investments Group first reported a position in CASC in Q4 2017 and held it in 1 quarter. The position peaked at $43K in Q4 2017. 1 fund tracked by Wall St. Rank holds CASC as of Q1 2018.

  • Russell Investments Group reported no remaining Cascadian Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Russell Investments Group sold 11,200 Cascadian Therapeutics, Inc. shares in Q1 2018, an estimated $43K.
  • Russell Investments Group first reported a position in Cascadian Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
  • Russell Investments Group's Cascadian Therapeutics, Inc. position peaked at $43K in Q4 2017.
  • 1 fund tracked by Wall St. Rank held Cascadian Therapeutics, Inc. as of Q1 2018.

Based on Russell Investments Group's 13F filing for Q1 2018, filed 11 May 2018.